Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -814 | -34 | 0 | -25 | -33 |
| Depreciation Amortization | 166 | N/A | N/A | N/A | N/A |
| Accounts receivable | -3,548 | N/A | N/A | N/A | N/A |
| Other Working Capital | -3,808 | -10 | 7 | 0 | 3 |
| Other Operating Activity | 4,101 | 0 | -28 | 0 | 0 |
| Operating Cash Flow | $-3,903 | $-43 | $-22 | $-25 | $-30 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -71 | N/A | N/A | N/A | N/A |
| Net Acquisitions | -1,766 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-1,836 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | -2 | 21 | 8 | 28 |
| Debt Issued | 6,236 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 50 | 100 | N/A | 20 |
| Common Stock Repurchased | N/A | N/A | -100 | N/A | N/A |
| Financing Cash Flow | $6,236 | $48 | $21 | $8 | $48 |
| Beginning Cash Position | 1,381 | 0 | 1 | 18 | 1 |
| End Cash Position | 1,878 | 5 | 0 | 1 | 18 |
| Net Cash Flow | $497 | $5 | $-1 | $-17 | $17 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,903 | -43 | -22 | -25 | -30 |
| Capital Expenditure | -71 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -3,973 | -43 | -22 | -25 | -30 |